D-serine Adjuvant Treatment Alleviates Behavioural And Motor Symptoms In Parkinson's Disease
| Effect | Decrease |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 13 |
| Gender | Both Genders |
| Age Range | 45-64, 65+ |
In persons with Parkinsons disease for at least 5 years and at stage II who were then given 30mg/kg D-serine daily for 6 weeks, it was found that the symptoms of Parkinsons as assessed by various measurement scales (UPDRS, SAS, and PNSS) and was well tolerated.